Everence Capital Management’s Mesa Laboratories MLAB Stock Holding History

Everence Capital Management’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,460	Closed	-$255	–	738
2023 Q1	$255	Hold	1,460	–	–	0.02%	598
2022 Q4	$243	Hold	1,460	–	–	0.02%	618
2022 Q3	$206K	Hold	1,460	–	–	0.02%	645
2022 Q2	$298K	Hold	1,460	–	–	0.03%	521
2022 Q1	$372K	Hold	1,460	–	–	0.03%	497
2021 Q4	$479K	Hold	1,460	–	–	0.04%	438
2021 Q3	$441K	Hold	1,460	–	–	0.04%	435
2021 Q2	$396K	Hold	1,460	–	–	0.03%	472
2021 Q1	$356K	Sell	1,460 -440	-23%	-$121K	0.03%	487
2020 Q4	$545K	Sell	1,900 -370	-16%	-$102K	0.05%	316
2020 Q3	$578K	Buy	2,270 +1,290	+132%	+$307K	0.06%	260
2020 Q2	$259K	Buy	+980	New	+$226K	0.03%	494

Other funds holding MLAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Everence Capital Management's MLAB Position: Q2 2023 in Review

Everence Capital Management sold out of Mesa Laboratories (MLAB) in Q2 2023, closing a stake of 1,460 shares — an estimated $255 sold.

Everence Capital Management first reported a position in MLAB in Q2 2020 and held it in 12 quarters. The position peaked at $578K in Q3 2020. 161 funds tracked by Wall St. Rank hold MLAB as of Q2 2023.

Everence Capital Management reported no remaining Mesa Laboratories position as of Q2 2023 after selling out during the quarter.
Everence Capital Management sold 1,460 Mesa Laboratories shares in Q2 2023, an estimated $255.
Everence Capital Management first reported a position in Mesa Laboratories in Q2 2020 and held it in 12 quarters.
Everence Capital Management's Mesa Laboratories position peaked at $578K in Q3 2020.
161 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2023.

Based on Everence Capital Management's 13F filing for Q2 2023, filed 14 Jul 2023.